Hepion Pharma Director Anand Reddi resigns from board effective Feb 7, 2024

Hepion Pharmaceuticals, Inc.

Anand Reddi resigned from Board of Directors on Feb 7, 2024.
He served as Chairman of Compensation Committee and member of Governance/Nominations Committee.
No successor appointed or reason for resignation disclosed.
Company did not provide any further details or comments on the departure.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Anand Reddi

Director

HEPA · Hepion Pharmaceuticals, Inc.

Effective: 2024-02-07
Filed: February 7, 2024, 6:59 PM ET

On February 7, 2024, Anand Reddi resigned from the Board of Directors of Hepion Pharmaceuticals, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Anand Reddi resigned as Director at Hepion Pharmaceuticals, Inc..

Action: resigned
Role: Director

Exact text from the filing

On February 7, 2024, Anand Reddi resigned from the Board of Directors of Hepion Pharmaceuticals, Inc.

View on SEC.gov

Hepion Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-011616

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.